NIVOLUMAB;RELATLIMAB-RMBW | B761234 | BRISTOL MYERS SQUIBB
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Mar. 18, 2034 | Active | Computed |
| 7-Year Orphan | Mar. 18, 2029 | Active | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12403174(composition) · relevance 92/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 658 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.